ARTICLE | Company News
CHMP backs Eylea for DME
June 27, 2014 11:50 PM UTC
EMA's CHMP backed approval of Eylea aflibercept from Bayer AG (Xetra:BAYN) to treat visual impairment due to diabetic macular edema. Eylea is approved in the U.S. and EU to treat wet age-related macul...